Jin Medical International Ltd. ( (ZJYL) ) has released a notification of late filing.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Company and Filing Details:
Jin Medical International Ltd. has filed a Form 12b-25 to notify investors of a delay in submitting its Form 20-F (Yearly Report) for the fiscal year ended September 30, 2025. The filing confirms that the company is a foreign private issuer and that the delayed report is its annual Form 20-F (Yearly Report), not a Form 10-Q (Quarter Report) or Form 10-K (Yearly Report).
Reason for Delay:
The company says it cannot file the Form 20-F (Yearly Report) by the prescribed deadline because it needs additional time to complete its review of the financial statements and finalize the annual report. The explanation points to extended internal review work rather than any specific external issue such as an auditor change, investigation, or formal internal control failure.
Expected Filing Timeline:
Jin Medical states that it expects to file the delayed Form 20-F (Yearly Report) no later than the fifteenth calendar day following the original due date, which is the standard grace period allowed under SEC rules when a Form 12b-25 is filed.
Financial Impact and Statements:
The company indicates that it does not anticipate any significant change in its results of operations compared with the prior fiscal year, as reflected in the earnings statements that will appear in the forthcoming Form 20-F (Yearly Report). No preliminary financial figures are provided, and any expectations about unchanged results should be viewed as forward-looking and subject to revision once the final audited numbers are released.
Next Steps and Signature:
Jin Medical confirms that all other required SEC periodic reports over the past 12 months have been filed, suggesting it remains broadly in compliance apart from this short delay. The notification is signed on behalf of the company by Chief Executive Officer Erqi Wang on January 30, 2026, underscoring management’s formal commitment to complete the filing within the allowed extension period and maintain its reporting obligations to investors.
More about Jin Medical International Ltd.
Jin Medical International Ltd. is a China-based company headquartered in Changzhou City, Jiangsu Province. While this specific filing does not describe its operations in detail, Jin Medical is known in the market as a manufacturer and provider of medical devices, with a focus on mobility and rehabilitation products. The company is listed in the United States and files its annual reports with the U.S. Securities and Exchange Commission as a foreign private issuer.
Average Trading Volume: 1,164,733
Technical Sentiment Signal: Sell
Current Market Cap: $23.98M
See more insights into ZJYL stock on TipRanks’ Stock Analysis page.